(No ratings)
Dr. Francine Samuels, MD is a pediatric gastroenterologist in New Hyde Park, NY specializing in pediatric gastroenterology.
She has a state license in New York.
Licensed In: New York
Dr. Francine Samuels, MD appears to accept the following insurance providers: Magnacare, Great West Healthcare, EmblemHealth Plan, Inc, Oscar, Fidelis, Multiplan, Affinity by Molina Healthcare, United Healthcare, Aetna, Tricare, Oxford, Medicare, Consumer Health Network, Empire Blue Cross Blue Shield, Healthfirst, Humana, Cigna, Coventry, Anthem Blue Cross Blue Shield, MVP Health Care, Connecticare, First Health Network, Private Healthcare Systems, Centivo, Northwell Direct Network, The New York State Health Insurance Program, CDPHP, Health Insurance Plan of Greater Network and Partners Health Plan.
According to our sources, Dr. Francine Samuels, MD accepts the following insurance providers:
Dr. Francine Samuels, MD does not have any reviews yet, be the first to leave a review of Dr. Francine Samuels, MD here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Francine Samuels, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| GENZYME CORPORATION |
$341
DUPIXENT $341 |
|||||
|---|---|---|---|---|---|---|
| Salix Pharmaceuticals, Ltd |
$128
Uceris $128 |
|||||
| Otsuka America Pharmaceutical, Inc. |
$123
BREATHTEK $123 |
|||||
| AbbVie Inc. |
$84
Creon $33 |
Humira $23 |
LINZESS $14 |
Skyrizi $14 |
||
| Salix Pharmaceuticals, a division of Bausch Health US, LLC |
$57
XIFAXAN $57 |
|||||
| Other |
$233
SUCRAID $54 |
LINZESS $42 |
ENTYVIO $32 |
VOQUEZNA $30 |
ZENPEP $28 |
Other $47 |
| Food and Beverage | $966 |
|---|
Dr. Francine Samuels' specialty is pediatric gastroenterology. She is a graduate of Weill Cornell Medical College. For her residency, Dr. Samuels trained at a hospital affiliated with Yale University. Dr. Samuels is professionally affiliated with Optum East. Dr. Samuels's practice in New York, NY is open to new patients as reported by Optum East.